Kew M C, Rossouw E, Paterson A, Hodkinson J, Whitcutt M, Dusheiko G
Gastroenterology. 1983 Apr;84(4):693-6.
The reason why hepatocellular carcinoma occurs less frequently in women than in men is unknown. The possibility that differences in the hepatitis B virus status between men and women with this tumor might be important in this regard was investigated in 75 black women and 75 age- and ethnically-matched men with hepatocellular carcinoma. Prevalences of hepatitis B surface antigen, core antibody alone, and total hepatitis B virus markers were not significantly different in the two sexes. It is concluded that women with hepatocellular carcinoma are just as likely as men to be, or to have been, infected with hepatitis B virus. Because the hepatitis B virus and contraceptive steroids might conceivably act as cocarcinogens, the age distribution of women with hepatocellular carcinoma was determined. Thirty-nine percent were of child-bearing age. Of these, 44% were positive for surface antigen and 17% for core antibody alone. Ninety percent of these women had one or more hepatitis B virus markers.
肝细胞癌在女性中比在男性中发病率更低的原因尚不清楚。在75名患有肝细胞癌的黑人女性和75名年龄及种族匹配的患有肝细胞癌的男性中,研究了该肿瘤患者中男女乙肝病毒感染状况的差异在这方面可能具有重要意义这一可能性。乙肝表面抗原、单纯核心抗体以及乙肝病毒标志物总数的患病率在两性中并无显著差异。得出的结论是,患有肝细胞癌的女性感染过乙肝病毒的可能性与男性相同。由于乙肝病毒和避孕类固醇可能被认为是共同致癌物,因此确定了患有肝细胞癌的女性的年龄分布。39%为育龄期。其中,44%表面抗原呈阳性,17%单纯核心抗体呈阳性。这些女性中有90%有一项或多项乙肝病毒标志物。